| Hans-Günter Meyer-Thompson | Buprenorphin
Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach.
Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach.
Caulfield MDG, Brar R, Sutherland C, Nolan S.
BMJ Case Rep. 2020 Mar 25;13(3). pii: e233715. doi: 10.1136/bcr-2019-233715.
Abstract